Clinical Trial Update: Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

This entry notes the completion of a Phase 3 trial evaluating different doses of fluvastatin for efficacy and safety in adults with mixed dyslipidemia or primar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Lescol (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Mixed Dyslipidemia, Hypercholesterolemia | Phase 3 | Status: COMPLETED